Chemical Compound Review:
Amlodis ethyl methyl2-(2- aminoethoxymethyl)-4-(2...
Synonyms:
Amlocard, Amlopres, Coroval, Intervask, Lipinox, ...
Mori,
Itoh,
Tajima,
Miller,
Byington,
Hunninghake,
Pitt,
Furberg,
Ligtenberg,
Blankestijn,
Oey,
Klein,
Dijkhorst-Oei,
Boomsma,
Wieneke,
van Huffelen,
Koomans,
Takebayashi,
Matsumoto,
Aso,
Inukai,
Whelton,
Barzilay,
Cushman,
Davis,
Iiamathi,
Kostis,
Leenen,
Louis,
Margolis,
Mathis,
Moloo,
Nwachuku,
Panebianco,
Parish,
Pressel,
Simmons,
Thadani,
Jollis,
Simpson,
Chowdhury,
Cascio,
Crouse,
Massing,
Smith,
Umemoto,
Kawahara,
Hashimoto,
Umeji,
Matsuda,
Tanaka,
Kubo,
Matsuzaki,
Toba,
Shimizu,
Miki,
Inoue,
Yoshimura,
Tsukamoto,
Sawai,
Kobara,
Nakata,
Jugdutt,
Menon,
Kumar,
Idikio,
Hobbs,
Gensini,
Mancini,
Manolis,
Bauer,
Böhler,
Genest,
Feldman,
Harvey,
Jenssen,
Metcalfe,
da Silva,
Rinaldi,
Linka,
Masani,
Avery,
Jones,
Saunders,
Hall,
Yasunari,
Maeda,
Watanabe,
Nakamura,
Yoshikawa,
Asada,
- Effect of amlodipine on morbidity and mortality in severe chronic heart failure. Prospective Randomized Amlodipine Survival Evaluation Study Group. Packer, M., O'Connor, C.M., Ghali, J.K., Pressler, M.L., Carson, P.E., Belkin, R.N., Miller, A.B., Neuberg, G.W., Frid, D., Wertheimer, J.H., Cropp, A.B., DeMets, D.L. N. Engl. J. Med. (1996)
- Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial. Agodoa, L.Y., Appel, L., Bakris, G.L., Beck, G., Bourgoignie, J., Briggs, J.P., Charleston, J., Cheek, D., Cleveland, W., Douglas, J.G., Douglas, M., Dowie, D., Faulkner, M., Gabriel, A., Gassman, J., Greene, T., Hall, Y., Hebert, L., Hiremath, L., Jamerson, K., Johnson, C.J., Kopple, J., Kusek, J., Lash, J., Lea, J., Lewis, J.B., Lipkowitz, M., Massry, S., Middleton, J., Miller, E.R., Norris, K., O'Connor, D., Ojo, A., Phillips, R.A., Pogue, V., Rahman, M., Randall, O.S., Rostand, S., Schulman, G., Smith, W., Thornley-Brown, D., Tisher, C.C., Toto, R.D., Wright, J.T., Xu, S. JAMA (2001)
- Gingival sequestration of amlodipine and amlodipine-induced gingival overgrowth. Ellis, J.S., Seymour, R.A., Thomason, J.M., Monkman, S.C., Idle, J.R. Lancet (1993)
- Efficacy of mibefradil compared with amlodipine in suppressing exercise-induced and daily silent ischemia: results of a multicenter, placebo-controlled trial. Tzivoni, D., Kadr, H., Braat, S., Rutsch, W., Ramires, J.A., Kobrin, I. Circulation (1997)
- Angiotensin AT1 receptor inhibition. Effects on hypertrophic remodeling and ACE expression in rats with pressure-overload hypertrophy due to ascending aortic stenosis. Weinberg, E.O., Lee, M.A., Weigner, M., Lindpaintner, K., Bishop, S.P., Benedict, C.R., Ho, K.K., Douglas, P.S., Chafizadeh, E., Lorell, B.H. Circulation (1997)
- Sex bias and underutilization of lipid-lowering therapy in patients with coronary artery disease at academic medical centers in the United States and Canada. Prospective Randomized Evaluation of the Vascular Effects of Norvasc Trial (PREVENT) Investigators. Miller, M., Byington, R., Hunninghake, D., Pitt, B., Furberg, C.D. Arch. Intern. Med. (2000)
- Effects of Ca2+ antagonists on motor activity and the dopaminergic system in aged mice. Kurosaki, R., Akasaka, M., Michimata, M., Matsubara, M., Imai, Y., Araki, T. Neurobiol. Aging (2003)
- Angiotensin II Receptor Blockers Downsize Adipocytes in Spontaneously Type 2 Diabetic Rats With Visceral Fat Obesity. Mori, Y., Itoh, Y., Tajima, N. Am. J. Hypertens. (2007)
- Patient compliance and therapeutic coverage: amlodipine versus nifedipine SR in the treatment of hypertension and angina: interim results. Steering Committee and Cardiologists and General Practitioners involved in the Belgium Multicentre Study on Patient Compliance. Detry, J.M. Clinical cardiology. (1994)
- Can combining different risk interventions into a single formulation contribute to improved cardiovascular disease risk reduction? Rationale and design for an international, open-label program to assess the effectiveness of a single pill (amlodipine/atorvastatin) to attain recommended target levels for blood pressure and lipids (The JEWEL Program). Hobbs, F.D., Gensini, G., Mancini, G.B., Manolis, A.J., Bauer, B., Böhler, S., Genest, J., Feldman, R., Harvey, P., Jenssen, T.G., Metcalfe, M., da Silva, P.M. International journal of cardiology. (2006)
- Reduction of sympathetic hyperactivity by enalapril in patients with chronic renal failure. Ligtenberg, G., Blankestijn, P.J., Oey, P.L., Klein, I.H., Dijkhorst-Oei, L.T., Boomsma, F., Wieneke, G.H., van Huffelen, A.C., Koomans, H.A. N. Engl. J. Med. (1999)
- Randomized, double-blind crossover study to investigate the effects of amlodipine and isosorbide mononitrate on the time course and severity of exercise-induced myocardial stunning. Rinaldi, C.A., Linka, A.Z., Masani, N.D., Avery, P.G., Jones, E., Saunders, H., Hall, R.J. Circulation (1998)
- Chronic amlodipine treatment during the development of heart failure. Spinale, F.G., Mukherjee, R., Krombach, R.S., Clair, M.J., Hendrick, J.W., Houck, W.V., Hebbar, L., Kribbs, S.B., Zellner, J.L., Dodd, M.G. Circulation (1998)
- Beneficial effects of amlodipine in a murine model of congestive heart failure induced by viral myocarditis. A possible mechanism through inhibition of nitric oxide production. Wang, W.Z., Matsumori, A., Yamada, T., Shioi, T., Okada, I., Matsui, S., Sato, Y., Suzuki, H., Shiota, K., Sasayama, S. Circulation (1997)
- Inhibition of cancer cell growth by calcium channel antagonists in the athymic mouse. Taylor, J.M., Simpson, R.U. Cancer Res. (1992)
- Calcium channel blockers and mortality in elderly patients with myocardial infarction. Jollis, J.G., Simpson, R.J., Chowdhury, M.K., Cascio, W.E., Crouse, J.R., Massing, M.W., Smith, S.C. Arch. Intern. Med. (1999)
- Vascular remodeling during healing after myocardial infarction in the dog model: effects of reperfusion, amlodipine and enalapril. Jugdutt, B.I., Menon, V., Kumar, D., Idikio, H. J. Am. Coll. Cardiol. (2002)
- Mechanism and clinical implication of insulin resistance syndrome. Suzuki, M., Ikebuchi, M., Shinozaki, K., Hara, Y., Tsushima, M., Matsuyama, T., Harano, Y. Diabetes (1996)
- Serum levels of thiobarbituric acid reactive substances predict cardiovascular events in patients with stable coronary artery disease: a longitudinal analysis of the PREVENT study. Walter, M.F., Jacob, R.F., Jeffers, B., Ghadanfar, M.M., Preston, G.M., Buch, J., Mason, R.P. J. Am. Coll. Cardiol. (2004)
- Oxidant stress leads to impaired regulation of renal cortical oxygen consumption by nitric oxide in the aging kidney. Adler, S., Huang, H., Wolin, M.S., Kaminski, P.M. J. Am. Soc. Nephrol. (2004)
- Amlodipine reduces transient myocardial ischemia in patients with coronary artery disease: double-blind Circadian Anti-Ischemia Program in Europe (CAPE Trial). Deanfield, J.E., Detry, J.M., Lichtlen, P.R., Magnani, B., Sellier, P., Thaulow, E. J. Am. Coll. Cardiol. (1994)
- Comparative effects of valsartan versus amlodipine on left ventricular mass and reactive oxygen species formation by monocytes in hypertensive patients with left ventricular hypertrophy. Yasunari, K., Maeda, K., Watanabe, T., Nakamura, M., Yoshikawa, J., Asada, A. J. Am. Coll. Cardiol. (2004)
- Preservation of endogenous antioxidant activity and inhibition of lipid peroxidation as common mechanisms of antiatherosclerotic effects of vitamin E, lovastatin and amlodipine. Chen, L., Haught, W.H., Yang, B., Saldeen, T.G., Parathasarathy, S., Mehta, J.L. J. Am. Coll. Cardiol. (1997)
- Effects of losartan and amlodipine on intrarenal hemodynamics and TGF-beta(1) plasma levels in a crossover trial in renal transplant recipients. Iñigo, P., Campistol, J.M., Lario, S., Piera, C., Campos, B., Bescós, M., Oppenheimer, F., Rivera, F. J. Am. Soc. Nephrol. (2001)
- Restenosis and clinical outcome in patients treated with amlodipine after angioplasty: results from the Coronary AngioPlasty Amlodipine REStenosis Study (CAPARES). Jørgensen, B., Simonsen, S., Endresen, K., Forfang, K., Vatne, K., Hansen, J., Webb, J., Buller, C., Goulet, G., Erikssen, J., Thaulow, E. J. Am. Coll. Cardiol. (2000)
- Clinical outcomes in antihypertensive treatment of type 2 diabetes, impaired fasting glucose concentration, and normoglycemia: Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Whelton, P.K., Barzilay, J., Cushman, W.C., Davis, B.R., Iiamathi, E., Kostis, J.B., Leenen, F.H., Louis, G.T., Margolis, K.L., Mathis, D.E., Moloo, J., Nwachuku, C., Panebianco, D., Parish, D.C., Pressel, S., Simmons, D.L., Thadani, U. Arch. Intern. Med. (2005)
- Aldosterone blockade attenuates urinary monocyte chemoattractant protein-1 and oxidative stress in patients with type 2 diabetes complicated by diabetic nephropathy. Takebayashi, K., Matsumoto, S., Aso, Y., Inukai, T. J. Clin. Endocrinol. Metab. (2006)
- Role of L-type calcium channel blocking in epidermal growth factor receptor-independent activation of extracellular signal regulated kinase 1/2. Yin, X., Polidano, E., Faverdin, C., Marche, P. J. Hypertens. (2005)
- Calcium [corrected] channel blockers reduce angiotensin II-induced superoxide generation and inhibit lectin-like oxidized low-density lipoprotein receptor-1 expression in endothelial cells. Toba, H., Shimizu, T., Miki, S., Inoue, R., Yoshimura, A., Tsukamoto, R., Sawai, N., Kobara, M., Nakata, T. Hypertens. Res. (2006)
- Different effects of amlodipine and enalapril on the mitogen-activated protein kinase/extracellular signal-regulated kinase kinase-extracellular signal-regulated kinase pathway for induction of vascular smooth muscle cell differentiation in vivo. Umemoto, S., Kawahara, S., Hashimoto, R., Umeji, K., Matsuda, S., Tanaka, M., Kubo, M., Matsuzaki, M. Hypertens. Res. (2006)
- Regression of atherosclerosis by amlodipine via anti-inflammatory and anti-oxidative stress actions. Yoshii, T., Iwai, M., Li, Z., Chen, R., Ide, A., Fukunaga, S., Oshita, A., Mogi, M., Higaki, J., Horiuchi, M. Hypertens. Res. (2006)